Very recently, Leng et al. [40] demonstrated that cell subpopulation, which concurrently expresses CD44+, EpCAM+ and Lgr5+, displays self-renewal capacity in preclinical models of CRC. This evidence concerns the gene EPCAM and colorectal carcinoma.